NCT06373354 Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
| NCT ID | NCT06373354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Architectural Distortions |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-10-18 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-10-18 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.
Eligibility Criteria
Inclusion Criteria: * Women undergoing standard screening mammography. * Ability to understand and sign consent. Exclusion Criteria: * Pregnant women. * Women unable to consent. * Male patients.
Contact & Investigator
Beatriz Adrada, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06373354 clinical trial?
This trial is open to female participants only, studying Architectural Distortions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06373354 currently recruiting?
Yes, NCT06373354 is actively recruiting participants. Contact the research team at beatriz.adrada@mdanderson.org for enrollment information.
Where is the NCT06373354 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06373354 clinical trial?
NCT06373354 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Beatriz Adrada, MD at M.D. Anderson Cancer Center. The trial plans to enroll 100 participants.